Novel Drug Approvals for 2025 | FDA FDA Novel Drug Therapy Approvals for 2025 In 2025, CDER approved 46 new drugs never before approved or marketed in the U S , known as “novel” drugs
Novel Drug Approvals for 2026 | FDA FDA Novel Drug Therapy Approvals for 2026 What are "Novel" Drugs? "Novel" drugs are new drugs never before approved or marketed in the U S See Drugs@FDA for information about all of CDER’s
Novel Drug Approvals for 2024 | FDA What are "Novel" Drugs? "Novel" drugs are new drugs never before approved or marketed in the U S See Drugs@FDA for information about all of CDER’s approved drugs and biological products FDA
Novel Drug Approvals for 2023 | FDA What are "Novel" Drugs? "Novel" drugs are new drugs never before approved or marketed in the U S See Drugs@FDA for information about all of CDER’s approved drugs and biological products FDA
Novel Drug Approvals for 2021 | FDA CDER’s novel drug approvals for 2021 are listed below For more information, download the report Advancing Health Through Innovation: New Drug Therapy Approvals for 2021
New Drug Therapy Approvals 2022 | FDA CDER’s Novel Drug Approvals of 2022 In 2022, CDER approved 37 novel drugs, either as new molecular entities (NMEs) under New Drug Applications (NDAs), or as new therapeutic biological products
Calendar